L505-0823 Screening compound: N-[2-(4-chlorophenyl)ethyl]-2-[2-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide

L505-0823 Screening compound: N-[2-(4-chlorophenyl)ethyl]-2-[2-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide
L505-0823 Screening compound: N-[2-(4-chlorophenyl)ethyl]-2-[2-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L505-0823
N-[2-(4-chlorophenyl)ethyl]-2-[2-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L505-0823

Molecular Formula

C19H19ClN4O2 (C19 H19 ClN4 O2)

Compound Name

N-[2-(4-chlorophenyl)ethyl]-2-[2-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide

IUPAC name

N-[2-(4-chlorophenyl)ethyl]-2-[2-(5-cyclopropyl-134-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide

SMILES

O=C(Cn1c(-c2nnc(C3CC3)o2)ccc1)NCCc(cc1)ccc1Cl

InChI

InChI=1S/C19H19ClN4O2/c20-15-7-3-13(4-8-15)9-10-21-17(25)12-24-11-1-2-16(24)19-23-22-18(26-19)14-5-6-14/h1-4,7-8,11,14H,5-6,9-10,12H2,(H,21,25)

InChI Key

OWHQTZXTODDLGM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27459058

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

370.84

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.106

Distribution Coefficient, logD

3.106

Water Solubility, LogSw

-3.53

Polar Surface Area

56.908

Acid Dissociation Constant (pKa)

14.28

Base Dissociation Constant (pKb)

2.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

L505-0823 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L505-0823 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L505-0823?
Check Price and Availability of L505-0823, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L505-0823 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L505-0823
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L505-0823
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L505-0823 available by request